Safety and efficacy of transarterial chemoembolization combined with tyrosine kinase inhibitors and camrelizumab in the treatment of patients with advanced unresectable hepatocellular carcinoma

ObjectiveThis study was aimed to evaluate the efficacy and safety of transarterial chemoembolization combined with tyrosine kinase inhibitors and camrelizumab in the treatment of unresectable hepatocellular carcinoma and to explore a new therapeutic strategy for the treatment of advanced HCC.Patient...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Jinpeng Li, Mingxin Kong, Guangji Yu, Song Wang, Zhaozhang Shi, Huihui Han, Yanyan Lin, Jutian Shi, Jinlong Song
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Frontiers Media S.A. 2023-07-01
Schriftenreihe:	Frontiers in Immunology
Schlagworte:	camrelizumab transarterial chemoembolization tyrosine kinase inhibitors unresectable hepatocellular carcinoma therapeutic evaluation
Online-Zugang:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1188308/full
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!